A Study to Evaluate the Safety and Efficacy of ASC40 (Denifanstat) Tablets in the Treatment of Patients With Moderate to Severe Acne Vulgaris
Clinical trial NCT06192264 · COMPLETED
Trial details
- NCT number
- NCT06192264
- Sponsor
- Ascletis Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-23
- Primary completion
- 2025-05-19
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.